{
    "Trade/Device Name(s)": [
        "Glucose Pilot Glucose Monitoring System",
        "Glucose Pilot Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Tianjin New Bay Bioresearch Co., Ltd.",
    "510(k) Number": "K052208",
    "Predicate Device Reference 510(k) Number(s)": [
        "K024194"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "December 9, 2005",
    "Summary Letter Received Date": "November 9, 2005",
    "Submission Date": "October 27, 2005",
    "Regulation Number(s)": [
        "21CFR862.1345",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Quantity Control Material"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Glucose Pilot Glucose Monitoring System (meter)"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution",
        "Lancing device",
        "Lancet"
    ],
    "Document Summary": "FDA 510(k) summary for Glucose Pilot Glucose Monitoring System for quantitative measurement of blood glucose using electrochemical biosensor technology.",
    "Indications for Use Summary": "For quantitative measurement of glucose in fresh capillary whole blood from a finger stick, intended for lay users and professionals as an aid to monitor diabetes control at home and in clinical settings.",
    "fda_folder": "Clinical Chemistry"
}